Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy
Public ClinicalTrials.gov record NCT01598831. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Safety and Efficacy of ART-123 in Subjects With Severe Sepsis and Coagulopathy.
Study identification
- NCT ID
- NCT01598831
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Asahi Kasei Pharma America Corporation
- Industry
- Enrollment
- 816 participants
Conditions and interventions
Conditions
Interventions
- ART-123 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 28, 2012
- Primary completion
- Apr 4, 2018
- Completion
- Feb 27, 2019
- Last update posted
- Apr 20, 2020
2012 – 2019
United States locations
- U.S. sites
- 22
- U.S. states
- 19
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mobile | Alabama | 36608 | — |
| Not listed | Phoenix | Arizona | 85008 | — |
| Not listed | Atlanta | Georgia | 30342 | — |
| Not listed | Idaho Falls | Idaho | 83404 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | Hazard | Kentucky | 41701 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Detroit Receiving Hospital | Detroit | Michigan | 48201 | — |
| Harper Hospital - Wayne State University School of Medicine | Detroit | Michigan | 48201 | — |
| Sinai-Grace Hospital | Detroit | Michigan | 48235 | — |
| Not listed | Jackson | Mississippi | 39216 | — |
| Washington University in St. Louis | St Louis | Missouri | 63110 | — |
| Not listed | Butte | Montana | 59701 | — |
| Not listed | Englewood | New Jersey | 07631 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Not listed | Durham | North Carolina | 27710 | — |
| Not listed | Columbus | Ohio | 43215 | — |
| Not listed | Oklahoma City | Oklahoma | 73104 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Rapid City | South Dakota | 57701 | — |
| 2 of 2 | Houston | Texas | 77030 | — |
| Not listed | Murray | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 139 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01598831, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01598831 live on ClinicalTrials.gov.